Literature DB >> 36268299

Effect of Ciprofloxacin, Levofloxacin, and Ofloxacin on Pseudomonas aeruginosa: A case control study with time kill curve analysis.

Tiar Sondang Uli Sihotang1, Agung Dwi Wahyu Widodo2, Pepy Dwi Endraswari2.   

Abstract

Background: Antibiotic resistance is closely related to therapy failure. Most antibiotic resistance is caused by delays in determining antibiotic agents, low administration doses, long periods between doses (inadequate pharmacokinetics) and single drug administration in infections caused by more than one pathogen. Treatment of Pseudomonas aeruginosa (P. aeruginosa) with ciprofloxacin, levofloxacin, and ofloxacin as monotherapy can lead to drug resistance, although combination therapy also does not provide a better outcome. Objective: To analyze the time-kill curve for P. aeruginosa and Multidrug resistance (MDR) P. aeruginosa.
Methods: This research is a case control study using isolates of P. aeruginosa ATCC 27853, clinical isolates of P. aeruginosa and MDR P. aeruginosa. Exposure of ciprofloxacin, levofloxacin, and ofloxacin to isolates with 1MIC, 2MIC, and 4MIC were then cultured at 0, 2, 4, 6, 8, 24 h of testing, then counting the number of colonies that grew and then analyzed by time-kill curve and statistical tests. The statistical test used in this study was the ANOVA and Mann-Whitney test with p < 0.05.
Results: Ciprofloxacin and ofloxacin achieved bactericidal activity, especially at a concentration of 4MIC. Levofloxacin ultimately achieved bactericidal activity at all concentrations. Statistical analysis showed there were significant differences in the number of colonies p < 0.001 in the second, fourth, sixth, and eighth hour between the three isolates, p < 0.001 in the sixth and second 4 h between 1MIC and 4MIC, p = 0.012 in the second 4 h between levofloxacin and ofloxacin antibiotics.
Conclusion: Levofloxacin has shown to have better bactericidal activity than ciprofloxacin, and ciprofloxacin has almost the same bactericidal activity as ofloxacin in vitro tests seen from the time-kill curve.
© 2022 The Authors.

Entities:  

Keywords:  Ciprofloxacin; Levofloxacin; Ofloxacin; Pseudomonas aeruginosa; Time-kill curve

Year:  2022        PMID: 36268299      PMCID: PMC9577630          DOI: 10.1016/j.amsu.2022.104674

Source DB:  PubMed          Journal:  Ann Med Surg (Lond)        ISSN: 2049-0801


  26 in total

Review 1.  Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: kill curves versus MIC.

Authors:  Markus Mueller; Amparo de la Peña; Hartmut Derendorf
Journal:  Antimicrob Agents Chemother       Date:  2004-02       Impact factor: 5.191

Review 2.  Quinolones in 2005: an update.

Authors:  F Van Bambeke; J-M Michot; J Van Eldere; P M Tulkens
Journal:  Clin Microbiol Infect       Date:  2005-04       Impact factor: 8.067

Review 3.  Distinguishing between resistance, tolerance and persistence to antibiotic treatment.

Authors:  Asher Brauner; Ofer Fridman; Orit Gefen; Nathalie Q Balaban
Journal:  Nat Rev Microbiol       Date:  2016-04       Impact factor: 60.633

4.  Comparative pharmacodynamics of clarithromycin and azithromycin against respiratory pathogens.

Authors:  A Bauernfeind; R Jungwirth; E Eberlein
Journal:  Infection       Date:  1995 Sep-Oct       Impact factor: 3.553

5.  Occurrence and characterization of carbapenem-resistant Gram-negative bacilli: A collaborative study of antibiotic-resistant bacteria between Indonesia and Japan.

Authors:  Kuntaman Kuntaman; Katsumi Shigemura; Kayo Osawa; Koichi Kitagawa; Koharu Sato; Naoki Yamada; Kento Nishimoto; Fukashi Yamamichi; Dadik Rahardjo; Usman Hadi; Ni Made Mertaniasih; Shohiro Kinoshita; Masato Fujisawa; Toshiro Shirakawa
Journal:  Int J Urol       Date:  2018-09-25       Impact factor: 3.369

Review 6.  Methods for in vitro evaluating antimicrobial activity: A review.

Authors:  Mounyr Balouiri; Moulay Sadiki; Saad Koraichi Ibnsouda
Journal:  J Pharm Anal       Date:  2015-12-02

7.  Comparison of in vitro static and dynamic assays to evaluate the efficacy of an antimicrobial drug combination against Staphylococcus aureus.

Authors:  Diane C Broussou; Pierre-Louis Toutain; Frédérique Woehrlé; Farid El Garch; Alain Bousquet-Melou; Aude A Ferran
Journal:  PLoS One       Date:  2019-01-23       Impact factor: 3.240

8.  Pharmacodynamic Functions of Synthetic Derivatives for Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA) and Mycobacterium tuberculosis.

Authors:  Mojdeh Dinarvand; Malcolm P Spain; Fatemeh Vafaee
Journal:  Front Microbiol       Date:  2020-11-27       Impact factor: 5.640

9.  Association of blood isolate's multi antibiotic resistance-index on laboratory-confirmed bloodstream infection: A cross-sectional study.

Authors:  Merry Puspita; Eddy Bagus Wasito; Lindawati Alimsardjono
Journal:  Ann Med Surg (Lond)       Date:  2021-11-23

10.  Comparative Activity of Ciprofloxacin, Levofloxacin and Moxifloxacin against Klebsiella pneumoniae, Pseudomonas aeruginosa and Stenotrophomonas maltophilia Assessed by Minimum Inhibitory Concentrations and Time-Kill Studies.

Authors:  Antoine Grillon; Frédéric Schramm; Magali Kleinberg; François Jehl
Journal:  PLoS One       Date:  2016-06-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.